A new regulation in China governing the collection, storage and transport of human genetic samples, including blood, saliva, tissues and cells, is expected to have a profound impact on biopharmaceutical R&D in the country, one of the most promising markets globally for this area of therapy.
The regulation has been seven years in the making after work was initiated back in 2012, and is set to...








